Clinical Trial Update: A Post-Marketing-Observational Study (PMOS) to Determine the Effectiveness of Combined Adalimumab Treatment and Active Supervised Training in Patients With Axial Spondyloarthritis (axSpA)

View source ↗

Summary

A post-marketing observational study investigating the effectiveness of combining adalimumab with active supervised training in axial spondyloarthritis has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: AbbVie | Conditions: Axial Spondyloarthritis | Status: TERMINATED | Results posted: 2019-10-02